SCHEMBL632317

SCHEMBL632317

C=COC(CCC)OC(=O)NC(CC)[Si](OCC)(OCC)OCC

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSK P43235 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28709212 0.84 CTSK (0.31) CTSK
SCHEMBL6660585 0.83 CTSK (0.31) CTSK
SCHEMBL9622385 0.77 CTSK (0.40) CTSK
SCHEMBL22655903 0.75 TSHR (0.32)
SCHEMBL28585921 0.74
SCHEMBL3401546 0.73 ACACB (0.32)
SCHEMBL9446372 0.72 ALDH1A1 (0.40) CTSK
SCHEMBL4245910 0.72 TSHR (0.42)
SCHEMBL1042116 0.72 SMN1; SMN2 (0.36)
SCHEMBL429578 0.72 CA1 (0.35) CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250319238-A1 COATING COMPOSITION FOR MEDICAL IMPLANTS TO PREVENT FOREIGN SUBSTANCE ADHESION LYNK SOLUTEC INC. (KR) 2025-10-16 US disclosed
CN-113840726-A Low loss composite layers and compositions for forming the same 罗杰斯公司 2021-12-24 CN disclosed
US-10926234-B2 Catalyst composition with mixed selectivity control agent and method W. R. GRACE & CO.-CONN. (US) 2021-02-23 US disclosed
US-20190247818-A1 Catalyst Composition With Mixed Selectivity Control Agent And Method W. R. GRACE & CO.-CONN. (US) 2019-08-15 US disclosed
US-10322394-B2 Catalyst composition with mixed selectivity control agent and method W. R. GRACE & CO.-CONN. (US) 2019-06-18 US disclosed
US-10207238-B2 Catalyst composition with mixed selectivity control agent and method W. R. GRACE & CO.-CONN. (US) 2019-02-19 US disclosed
EP-2315790-B1 HIGH MELT FLOW PROPYLENE IMPACT COPOLYMER AND METHOD GRACE W R & CO (US) 2018-04-25 EP disclosed
US-9434796-B2 Catalyst composition with alkoxyalkyl ester internal electron donor and polymer from same W. R. GRACE & CO.-CONN. (US) 2016-09-06 US disclosed
US-9382343-B2 Procatalyst composition with alkoxypropyl ester internal electron donor and polymer from same W. R. GRACE & CO.-CONN. (US) 2016-07-05 US disclosed
US-9382342-B2 Procatalyst composition with alkoxyalkyl 2-propenoate internal electron donor and polymer from same W. R. GRACE & CO.-CONN. (US) 2016-07-05 US disclosed
EP-2315790-A1 HIGH MELT FLOW PROPYLENE IMPACT COPOLYMER AND METHOD Dow Global Technologies LLC (US) 2011-05-04 EP disclosed
US-7893003-B2 Catalyst composition with mixed selectivity control agent and method DOW GLOBAL TECHNOLOGIES INC. (US) 2011-02-22 US disclosed
WO-2010123775-A1 PROCATALYST COMPOSITION WITH ADAMANTANE AND METHOD DOW GLOBAL TECHNOLOGIES INC. (US) 2010-10-28 WO disclosed
US-20100273966-A1 Procatalyst Composition with Adamantane and Method W. R. GRACE & CO.-CONN. 2010-10-28 US disclosed
US-20100267911-A1 Procatalyst Composition with Silyl Glutarate and Method DOW GLOBAL TECHNOLOGIES INC. (US) 2010-10-21 US disclosed
WO-2010120973-A1 PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD DOW GLOBAL TECHNOLOGIES INC. (US) 2010-10-21 WO disclosed
WO-2010082943-A1 HIGH MELT FLOW PROPYLENE IMPACT COPOLYMER AND METHOD DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-22 WO disclosed
WO-2010021762-A1 CATALYST COMPOSITION WITH MIXED SELECTIVITY CONTROL AGENT AND POLYMERISATION METHOD USING IT DOW GLOBAL TECHNOLOGIES INC. (US) 2010-02-25 WO disclosed
US-20090209706-A1 High Melt Flow Propylene Impact Copolymer and Method W. R. GRACE & CO.-CONN. 2009-08-20 US disclosed
US-20090203863-A1 Catalyst Composition with Mixed Selectivity Control Agent and Method W. R. GRACE & CO.-CONN. 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267911-A1 Procatalyst Composition with Silyl Glutarate and Method MPST, TST, TKT CTSK 1782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.